companydata.dkBiomedica-Anpartsselskab: Financial statements 2024
CVR: 15234474
Biomedica-Anpartsselskab (CVR 15234474) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 395,337 and a net result of DKK 307,277 compared with DKK 588,686 the year before. That is a decrease of 47.6% compared with the year before. Equity amounted to DKK 2,730,410. The solvency ratio was 96.2%. The company had 1 employee in the financial year.
- Gross Profit
- 395,337 kr.
- Profit/Loss
- 307,277 kr.
- Equity
- 2,730,410 kr.
- Total Assets
- 2,837,398 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 395 t. | 307 t. | 2.7 mio. | 1 |
| 2023 | - | 755 t. | 589 t. | 2.4 mio. | 0 |
| 2022 | - | 640 t. | 498 t. | 1.8 mio. | - |
| 2021 | - | 512 t. | 402 t. | 1.3 mio. | - |
| 2020 | 2 mio. | 1.1 mio. | 828 t. | 916 t. | - |
How creditworthy is Biomedica-Anpartsselskab?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
Biomedica-Anpartsselskab has published its annual report for 2023. Gross profit came to DKK 754,666, and the net result was DKK 588,686.
About Biomedica-Anpartsselskab
Biomedica-Anpartsselskab is a Danish company of the type Anpartsselskab based in Frederiksberg C, founded in 1991. The company is registered under the industry Vikarbureauers aktiviteter og anden personaleformidling. The management consists of Lars Anders Baumbach. The company is owned by Lars Anders Baumbach. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -28,050 compared with DKK 307,277 the year before. Equity amounted to DKK 2,702,360.